Barry Ticho - Mar 15, 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jonathan Allan, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Mar 15, 2025
Transactions value $
$0
Form type
4
Date filed
3/18/2025, 04:08 PM
Previous filing
Dec 11, 2024
Next filing
Mar 20, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STOK Common Stock Options Exercise $0 +13.1K +29.28% $0.00 57.8K Mar 15, 2025 Direct
transaction STOK Common Stock Options Exercise $0 +10K +17.29% $0.00 67.8K Mar 15, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Restricted Stock Units Options Exercise $0 -13.1K -33.33% $0.00 26.2K Mar 15, 2025 Common Stock 13.1K Direct F1, F2
transaction STOK Restricted Stock Units Options Exercise $0 -10K -25% $0.00 30K Mar 15, 2025 Common Stock 10K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
F2 The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date.
F3 The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the issuer through each vesting date.